Severe Immune Thrombocytopenia Post-COVID-19: A Case Report

  • Davoodian A
  • Umeh C
  • Novatcheva E
  • et al.
N/ACitations
Citations of this article
19Readers
Mendeley users who have this article in their library.

Abstract

Immune thrombocytopenia, also called idiopathic thrombocytopenic purpura, is a common cause of thrombocytopenia after viral infections. Even in the second year of the coronavirus disease 2019 (COVID-19) pandemic, our body of knowledge regarding the diverse symptoms and complications of the virus continues to grow and evolve. We present a case of a 48-year-old African American male who came into the emergency department with severe left foot pain. A platelet count of 7x10(3)/mL was incidentally found on complete blood count (CBC) during the patient's initial workup. The patient had previously been hospitalized for COVID-19 five weeks prior. Further workup did not support any etiology of his thrombocytopenia. Therefore, we gave a presumed diagnosis of idiopathic thrombocytopenic purpura secondary to COVID-19. The patient was treated with corticosteroid resulting in improvement in his platelet count.

Cite

CITATION STYLE

APA

Davoodian, A., Umeh, C., Novatcheva, E., Sassi, G. P., Ahaneku, H., & Kundu, A. (2021). Severe Immune Thrombocytopenia Post-COVID-19: A Case Report. Cureus. https://doi.org/10.7759/cureus.19544

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free